Journal Article Summary
The article investigates the effectiveness of budesonide/formoterol (Symbicort®) as an alternative reliever medication for mild to moderate asthma attacks, comparing it to the traditional nebulized salbutamol. This topic is significant because asthma exacerbations can be severe and require immediate treatment. With recent respiratory outbreaks raising concerns about the safety of nebulization, exploring alternative delivery methods for asthma relief is crucial for patient safety and treatment efficacy.
In this randomized open-label trial conducted in an emergency department, 32 adult patients with mild to moderate asthma attacks were assigned to receive either Symbicort® or nebulized salbutamol. The study measured various objective parameters, such as oxygen saturation and peak expiratory flow rate, as well as subjective assessments of symptom relief. The results indicated that both treatments led to significant improvements in the measured parameters within the first 15 minutes, with no notable differences between the two medications in terms of effectiveness.
However, the study has limitations, including a small sample size and the lack of blinding, which may affect the reliability of the findings. Additionally, factors such as patients' comorbidities and smoking status were not considered, which could influence treatment outcomes. Patients should discuss these findings with their healthcare providers, particularly regarding the use of Symbicort® as a potential alternative reliever, and ensure they understand the importance of adhering to prescribed maintenance therapies to prevent severe asthma exacerbations.
Medical Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Chew Keng Sheng, Kamarudin Hamizah, Hashim Che Wan. A randomized open-label trial on the use of budesonide/formoterol (Symbicort®) as an alternative reliever medication for mild to moderate asthmatic attacks. International Journal of Emergency Medicine 2012. DOI: 10.1186/1865-1380-5-16. PMID: 22503137. PMCID: PMC3352303.
Featured Pill Pals Product
Albuterol 90 MCG Inhaler --- Equivalent to Proair --- Lupin Pharma
Albuterol 90 MCG Inhaler — Equivalent to Proair — Lupin Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
